Correlation of clinical, biochemical and radiological characteristics with histopathology of ovarian masses: hospital based descriptive study
Keywords:Ovarian tumours, Risk of malignancy index, Benign ovarian masses
Background: Ovarian cancer is an important cause of morbidity and mortality in the middle aged women. A systematic study of all ovarian tumours encountered in a large institute over a period of years is more likely to produce a significant amount of useful data regarding the clinical manifestations, the incidence of various types of ovarian tumours and the type of treatment offered. In this study we correlate various clinical presentations, ultrasound features, and various tumour marker levels with histopathology of ovarian masses.
Methods: The study was conducted in the department of obstetrics and gynaecology in collaboration with department of radiology and pathology and lab medicine, Deen Dayal Upadhyay hospital from April 2015 to December 2016.
Results: In the present study, 97 ovarian masses have been operated out of total 708 gynaecological surgeries in the obstetrics and gynaecology department of Deen Dayal Upadhyay hospital over the stipulated period. Prevalence of ovarian masses was 13.7%. Most of the ovarian masses were prevalent in the reproductive age group i.e. 21-40 years of age group in the present study though malignant masses were commonest in post-menopausal age group in the present study. 2 out 11 malignant ovarian masses were in the age group of 10-20 years which were dysgerminoma and immature teratoma respectively. Intra-operative findings like presence of mural nodule, haemorrhage and necrosis, ascites, papillary excrescences and omental caking were also found to have strong correlation with malignancy.
Conclusions: A detailed preoperative workup and a simple tool loke RMI can differentiate between benign and malignant masses pre-operatively especially in post-menopausal women.
United States cancer statistics: 1999-2013, incidence and mortality web-based report. Available at: https://wonder.cdc.gov/wonder/help/CancerMIR-v2013.html. Accessed on 25 June 2020.
McCorkle R, Pasacreta J, Tang ST. The silent killer: psychological issues in ovarian cancer. Holistic nursing practice. 2003;17(6):300-8.
Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstetrics & Gynecology. 1999;93(3):448-52.
Zahra F. Pattern of benign ovarian cysts in Qatari women. Qatar medical journal. 2017;2016(2):17.
Rashmi KS, Patil SB. Clinicopathological study of ovarian tumours. Perspective of clinical research. 2016;4(3):27-31.
Patel A, Patel P, Karena Z, Vyas K. A retrospective analytic study of clino-histopathological correlation of ovarian mass. International Journal of Reproduction, Contraception, Obstetrics and Gynaecology. 2016;5(11):3802-5.
Kanthikar SN, Dravid NV, Deore PN, Nikumbh DB, Suryawanshi KH. Clinico-histopathological analysis of neoplastic and non-neoplastic lesions of the ovary: a 3-year prospective study in Dhule, North Maharashtra, India. Journal of clinical and diagnostic research. 2014;8(8):FC04.
Cancer 2015; American cancer society. Available at: file:///C:/Users/DRC453~1.PRI/AppData/Local/Temp/cancer-facts-and-figures-2015.pdf. Accessed on on 25 June 2020.
Leeuwen FE, Klip H, Mooij TM, Swaluw AM, Lambalk CB, Kortman M, et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Human reproduction. 2011;26(12): 3456-65.
Richardson DL. ACOG commitee opinion summary. Obstet Gynecol. 2017;130:e146-9.
Wills V, Mathew R. A study on clinico-histopathological patterns of ovarian tumours. International Journal of Reproduction, Contraception, Obstetrics and Gynaecology. 2017;5 (8):2666-71.
Deeba F, Khatun S, Alam MM, Shahida SM. Serum LDH and CA-125: markers for diagnosis of ovarian malignancy. Mymensingh medical journal. 2015;24 (2):334-40.
Karimi-Zarchi M, Mojaver SP, Rouhi M, Hekmatimoghaddam SH, Moghaddam RN, Yazdian-Anari P, Teimoori S. Diagnostic value of the risk of malignancy index (RMI) for detection of pelvic malignancies compared with pathology. Electronic physician. 2015;7(7):1505.
Mamlouk MD, Shankar S, Silverman SG. Omental cakes: unusual aetiologies and CT appearances. Insights into imaging. 2011;2(4):399-408.